Tetra­kis{2-[2-(2,6-dichloro­anilino)phen­yl]ethano­ato-κ2 O:O′}bis­[(dimethyl sulfoxide-κO)copper(II)](Cu—Cu): a binuclear CuII complex with the non-steroidal anti-inflammatory drug diclofenac

The title compound, [Cu2(C14H10Cl2NO2)4(C2H6OS)2], comprises a CuII 2 core that is quadruply bridged by four carboxyl­ate ligands with the dimethyl sulfoxide ligands binding along the Cu⋯Cu axis. The four carboxyl­ate ligands bind in a bidentate syn–syn bridging mode. Mol­ecules reside on crystallographic inversion centres bis­ecting the mid-point of the Cu⋯Cu axis. There are no inter­molecular inter­actions of note

Platinum(II) and Palladium(II) Complexes of Pyridine-2-Carbaldehyde Thiosemicarbazone as Alternative Antiherpes Simplex Virus Agents

The cytotoxicity and the antivirus activity of Pd(II) and Pt(II) complexes with pyridine-2-carbaldehyde thiosemicarbazone (HFoTsc) against HSV replication were evaluated on four HSV strains—two wt strains Victoria (HSV-1) and BJA (HSV-2) and two ACVR mutants with different tk gene mutations R-100 (TKA, HSV-1) and PU (TKN, HSV-2). The experiments were performed on continuous MDBK cells and four HSV 1 and HSV 2 strains were used, two sensitive to acyclovir and two resistant mutants. The five complexes of HFoTsc, [Pt(FoTsc)Cl], [Pt(FoTsc)(H2FoTsc)]Cl2, [Pt(FoTsc)2], [Pd(FoTsc)(H2FoTsc)]Cl2, and [Pd(FoTsc)2], were found to be effective inhibitors of HSV replication. The most promising, active, and selective anti-HSV agent was found to be complex [Pt(FoTsc)(H2FoTsc)]Cl2. This complex could be useful in the treatment of HSV infections, since it is resistant to ACV mutants. PCR study of immediate early 300 bp ReIV Us1 region reveals that the complex [Pt(FoTsc)(H2FoTsc)]Cl2 specifically suppressed wt HSV-1 genome 2 hours after the infection, not inducing apoptosis/necrosis on the 8 hours after virus infection. The target was found to be most probably the viral, instead of the host cell DNA

(E)-2-[1-(3-Chloro-4-fluoro­phen­yl)ethyl­idene]hydrazinecarbothio­amide

In the crystal of the title compound, C9H9ClFN3S, the molecules are inter­connected by N—H⋯S and N—H⋯F hydrogen bonds. There are two different N—H⋯S hydrogen bond: the stronger one links mol­ecules into infinite chains along the b axis with graph-set motif C(4), while the weaker N—H⋯S hydrogen bond combines with the previous one into an R 2 2(8) network. Moreover, the chains are linked into layers parallel to (102) by weak N—H⋯F hydrogen bonds, which form an R 2 2(22) ring motif. In addition, there are also weak π–π inter­actions between the benzene rings of adjacent mol­ecules [centroid–centroid distance = 3.8997 (15) Å]

Organotin Compound Derived from 3-Hydroxy-2-formylpyridine Semicarbazone: Synthesis, Crystal Structure, and Antiproliferative Activity

The novel diphenyltin(IV) compound [Ph2(HyFoSc)Sn] (2), where H2HyFoSc (1) is 3-hydroxy-2-formylpyridine semicarbazone, was prepared and characterized by vibrational and NMR (1H, 13C) spectroscopy. The structure of [Ph2(HyFoSc)Sn] was confirmed by single-crystal X-ray crystallography. The doubly deprotonated ligand is coordinated to the tin atom through the enolic-oxygen, the azomethine-nitrogen, and phenolic-oxygen, and so acts as an anionic tridentate ligand with the ONO donors. Two carbon atoms complete the fivefold coordination at the tin(IV) center. Intermolecular hydrogen bonding, C–H → π, and π → π interactions combine to stabilize the crystal structure. Compounds 1 and 2 have been evaluated for antiproliferative activity in vitro against the cells of three human tumor cell lines: MCF-7 (human breast cancer cell line), T24 (bladder cancer cell line), A549 (nonsmall cell lung carcinoma), and a mouse fibroblast L-929 cancer cell line

Dichlorido{4-cyclo­hexyl-1-[1-(2-pyridyl-κN)ethyl­idene]thio­semicarbazidato-κ2 N 1,S}methyl­tin(IV)

The monodeprotonated Schiff base ligand in the title compound, [Sn(CH3)(C14H19N4S)Cl2], N,N′,S-chelates to the Sn atom, which is six-coordinated in an octa­hedral environment. The three coordinating atoms along with the methyl C atom comprise a square plane, above and below which are positioned the Cl atoms. The amino group is a hydrogen-bond donor to a Cl atom of an adjacent mol­ecule, the hydrogen bond giving rise to a helical chain extending parallel to [100]

5-Bromo-N-(3,4-dimeth­oxy­benz­yl)pyridin-2-amine

The title compound, C14H15BrN2O2, an inter­mediate in drug discovery, was synthesized by the reaction of 5-bromo­pyridin-2-amine and 3,4-dimeth­oxy­benzaldehyde. In the crystal, molecules are linked via pairs ofN—H⋯N hydrogen bonds, leading to the formation of inversion dimers. A short contact occurs between the aryl H atom (ortho position from N) and the centroid of the benzene ring

(E)-3,4-Dihydroxy­benzaldehyde 4-ethyl­thio­semicarbazone

The title compound, C10H13N3O2S, was prepared by condensation of 3,4-dihydroxy­benzaldehyde with 4-ethyl-3-thio­semicarbazide. The mol­ecule adopts an E configuration with respect to the C=N bond. One of the OH substituents on the dihydroxy­benzene ring is disordered over the two possible 3-positions on either side of the ordered 4-hydr­oxy group. The occupancy of the major disorder component refined to 0.633 (7). The mol­ecule is essentially planar, with an r.m.s. deviation through all non-H atoms of 0.0862 Å. An intra­molecular N—H⋯N hydrogen bond forms between the outer amine residue and the imine N atom, generating an S(5) ring motif and contributing to the planarity of the mol­ecule. In the crystal structure, an extensive network of classical O—H⋯O, O—H⋯S and N—H⋯S hydrogen bonds and weak C—H⋯O and S⋯O [3.301 (3) Å] inter­actions link mol­ecules into sheets running approximately parallel to the ab plane